Navigation Links
DIA 3rd Annual Clinical Trial Disclosure Workshop Offers Strategies for Creating Effective Registries and Results Databanks
Date:8/20/2009

The Drug Information Association (DIA) will host its 3rd Annual Clinical Trial Disclosure Workshop (October 6-8, 2009; National Harbor, MD).

Horsham, PA, USA (Vocus) August 20, 2009 -- The Drug Information Association (DIA) will host its 3rd Annual Clinical Trial Disclosure Workshop (October 6-8, 2009; National Harbor, MD).

This three-day workshop will feature interactive discussions with government, biopharmaceutical, medical device, and data standards experts on how to ensure compliance and improve efficiency in clinical trial disclosure.

FEATURED TOPICS

 
  • Global Requirements, Laws, Regulations and Business Cases
  • Defining the Clinical Trial Disclosure Role within a Company
  • Available Tools, Resources, Organizations
  • Impact of External Stakeholders, Company Policies, and Advanced Technologies on
  • Disclosure Processes
  • Key Milestones for Managing Compliance
  • Quality Checks
"Evolving clinical trial registration and results disclosure requirements are significantly increasing the workload of clinical operations and medical affairs departments," says Program Co-chair Tracy Beck, PhD, Associate Global Medical Business Office Consultant; CTR Results Gatekeeper, Eli Lilly and Company. "This workshop will present real-world approaches to the clinical trial registration and results disclosure process."

A preconference tutorial titled, Clinical Trial Results Registration, will be held on October 6. This hands-on tutorial is designed to guide participants in creating accurate and effective study results to www.ClinicalTrials.gov.

For tabletop exhibit opportunities contact Jeff Korn at Jeff.Korn(at)diahome(dot)org.

Click here to register for the 3rd Annual Clinical Trial Disclosure Workshop.

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
DIA
+1-215-293-5812
Joe.Krasowski(at)diahome(dot)org

# # #

Read the full story at http://www.prweb.com/releases/DIA/clinical_trial_disclosure/prweb2775064.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Florida Gentle Dental Dentists Giving Away Smile Makeover and Orthodontic Braces at 7th Annual Our Kids World Family Fun Festival
2. Lightspeed Research -- The Foresight Group, Announced Today the Annual Meeting for The Healthcare Consortium
3. Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting
4. Rodman Renshaw Annual Global Investment Conference in New York on September 10, 2009
5. Eva Longoria Parker and George Lopez Return to Host 9th Annual PADRES Contra El Cancers EL SUENO DE ESPERANZA Gala
6. The Dannon Company Awards Cornell Cooperative Extension of Westchester County the Fourth Annual Dannon Next Generation Nutrition Grant
7. The Dannon Company Awards Fourth Annual Dannon Next Generation Nutrition Grants Supporting Nutrition Education for Children
8. Sebastian Ferrero Foundation to Host 2nd Annual Fundraiser, Noche de Gala
9. Patient Placement Systems Presents a Session at the THCA 2009 Annual Convention
10. VA Secretary Addresses 65th Annual AMVETS Convention
11. Scott Hamiltons Return to the Ice Scheduled for the 10th Annual An Evening With Scott Hamilton and Friends on Saturday, Nov. 7, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DIA 3rd Annual Clinical Trial Disclosure Workshop Offers Strategies for Creating Effective Registries and Results Databanks 
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
Breaking Medicine Technology: